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Uncontrolled ﬁbrous protein aggregation is implicated in a range of aberrant biological phenomena.
Much effort has consequently been directed towards establishing quantitative in vitro assays of this
process with the aim of probing amyloid growth in molecular detail as well as elucidating the effect
of additional species on this reaction. In this paper, we discuss some recent approaches based on
label-free technologies focussed on achieving these objectives. Several biosensor techniques have
been developed to monitor biomolecular assembly without the requirement for ﬂuorophore marker
molecules; in particular quartz crystal microbalance and surface plasmon resonance measurements
provide advantageous alternatives to traditional spectroscopic methods and are currently receiving
increasing attention in the context of amyloid growth assays.
 2009 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Biological functionality provided by protein molecules in living
systems is in general contingent on their reliable folding into the
native structures encoded in their polypeptide sequences. It is
increasingly appearing, however, that polypeptide chains also pos-
sess an inherent tendency to access an alternative ordered phase
where non-native contacts are formed between adjacent molecules
condensed into supra-molecular assemblies [1–3]. Such elongated
nanostructures, commonly known as amyloid or amyloid-like ﬁ-
brils, are implicated in a wide range of pathological conditions
including many neurodegenerative diseases as well as localised
and systemic amyloidoses [1,4–6]. In addition, it has recently been
established that in select cases amyloid-like structures can also
possess beneﬁcial biological functionality, for instance as functional
bacterial coatings [7–9], as epigenetic switches [10–14], as control-
ling factors in fungal cell fusion [15,16] and as catalytic scaffolds in
melanin synthesis [17]. This natural use of amyloid assembly for
functional purposes in biological systems has provided inspiration
for the investigation of tailored amyloid-like structures as bion-
anomaterials for technological applications [18–25].
Soluble forms of many different proteins are capable of trans-
forming into insoluble amyloid structures under a variety of phys-
iological and non-physiological conditions [2,26]. In order tochemical Societies. Published by Edevelop a fundamental understanding of the factors which pro-
mote, or on the contrary inhibit, this transition which lies at the
heart of biological function and malfunction, it is essential to be
able to probe the thermodynamics and kinetics of this process in
a reliable way. Traditional experimental methods have focussed
on the use of amyloidophilic dyes such as Congo red or thioﬂavin
T which, upon binding to amyloid ﬁbrils, exhibit a change in their
spectral properties which can be measured using optical spectros-
copy in a conventional manner. Such approaches, however, suffer
from their dependence on the knowledge of stoichiometry, sensi-
tivity and mechanism of dye binding [27–30]; aspects which cur-
rently remain challenging to quantify. Many of these problems
can be avoided when protein monomers are covalently labeled
with ﬂuorophores [31], but in such cases care is required in order
to ensure that the label does not affect ﬁbril morphology or aggre-
gation kinetics.
Direct, label-free measurements represent an alternative and
complementary approach to traditional protein aggregation assays.
These direct approaches circumvent the complexities associated
with the design, synthesis and detailed understanding of the mech-
anism of action of ﬂuorophores and the inﬂuences they may have
on the aggregation reaction. Of particular interest are several la-
bel-free surface techniques based on biosensors that have been
developed recently and applied to protein aggregation. The general
strategy behind such assays is to exploit coupling between the
amyloid growth reaction on a sensor surface and the mechanical
or optical response of the sensor. We discuss here two such ap-
proaches which rely on surface plasmon resonance and mechanical
transduction.lsevier B.V. All rights reserved.
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transducers
We ﬁrst focus on the monitoring of amyloid growth through di-
rect measurements, using quartz crystal microbalances, of the
mass increase as new protein molecules add on to amyloid ﬁbrils.
The operation of a quartz crystal microbalance (QCM) relies on the
high sensitivity of the resonant frequency of a mechanical oscilla-
tor to the mass which is in movement. In practice the inverse
piezo-electric effect is commonly used to transduce oscillating
electric ﬁelds into acoustic shear waves in thin quartz crystals,
resulting typically in resonant frequencies in the megahertz range
for the fundamental frequency. The surface of the sensor is on an
anti-node of the shear wave, and therefore any changes in surface
mass loading consequently are reﬂected accurately in the resonant
frequency of the system. First applications of this principle [32] for
practical mass sensing focussed on gas phase adsorption as this
provided an environment free from mechanical perturbation or
temperature ﬂuctuations that can affect the frequency of the crys-
tal. Signiﬁcant advances in the 1980s demonstrated the use of QCM
in liquid environments [33,34] and as biosensors [35,36] and in re-
cent years there has been increasing interest in applying mechan-
ical resonators as the basis for bio- and immuno-sensing [36–40].
In order to use QCM methodology as the basis for an amyloid
growth assay, the protein aggregation reaction has to be directed
on to the sensor surface where the changes in mass can be detected
effectively. One possibility in this respect is to create speciﬁc
growth sites on a functionalised surface. This type of functionalisa-
tion can be achieved by covalently attaching small pre-formed
aggregates [41–43] to the sensor surface; when exposed to soluble
protein under aggregation promoting conditions, the monomers
present in solution can add on to such seed aggregates, resulting
in amyloid growth (Fig. 1b). The controlled preparation of such sur-
faces is essential for reproducible measurements to be achieved;Tim
0 40
0
20
40
60
80
R
es
po
ns
e 
(R
U
)
c
Time (s)
ΔF
 (H
z)
-50
-100
-150
-200
0 200 400 600 800
a
db
Fig. 1. Label-free measurements of amyloid ﬁbril elongation. In the schematic diagrams
yellow spheres, immobilised seed ﬁbrils are shown in blue and the yellow ﬁbril ends rep
d): SPR, (e–f) cantilever sensors. (a) A negative shift in resonant frequency is observed u
under the same conditions exhibit a very low response (a, green line and b, upper schem
monomeric protein to Ab(1–40) seed ﬁbrils, subsequent dissociation is also observed u
(green line). In (e–f) the differential surface stress generated by growing insulin ﬁbrils
solutions is used as a probe for amyloid growth. Data from [41,60,81].the ﬁxation of seed ﬁbrils on to gold surfaces can either exploit nat-
urally occurring surface exposed sulfhydryl groups within cysteine
residues of the polypeptide chains composing the aggregates, or
when these are absent, speciﬁc linker molecules can be used to
guarantee effective binding of seed ﬁbrils to the sensor surface
[42,43]. The remaining exposed area of the surface can then be pas-
sivated using an inert thiol-terminated self-assembling monolayer
which binds to the free exposed gold surface and prevents
non-speciﬁc protein adsorption. It has been demonstrated that this
approach enables reliable assays of protein aggregation to be
developed for different proteins such as insulin [41], a range of
mutants of the SH3 domain (Fig. 2a and b) [42] and the Ab peptide
[43].
Due to the high sensitivity of QCMs to mass increase at the so-
lid–liquid interface, amyloid growth rates for a given set of condi-
tions can be measured in many cases within a matter of minutes
(Fig. 1a); this situation is in contrast to traditional aggregation as-
says, where typically hours or days are required to measure the
time for the conversion of soluble protein into ﬁbrils. In addition,
lower detection limits can be achieved with QCM sensors com-
pared to ﬂuorescent assays; for instance for the case of the Ab pep-
tide, aggregation rates could be measured for concentrations of
soluble peptide as low as 500 nM, a value approximately one order
of magnitude lower than the limits reported for traditional ﬂuores-
cent assays [43]. A further advantage of biosensor measurements is
that the growth of the same ensemble of ﬁbrils can be probed
repeatedly under different conditions simply by changing the
growth solution in contact with the ﬁbrils bound to the sensor; a
possibility which is absent if both the monomers and the ﬁbrils
are in solution.
An alternative approach to the growth of pre-formed seed ﬁbrils
on a sensor is to initiate the reaction with monomeric protein in
solution and let polymerisation take place de novo starting from
the nucleation step at the solid–liquid interface [44–46]. In partic-e (s)
80 120
0.1
0
-0.1
-0.2
-0.3
0 4 8 12
Su
rfa
ce
 S
tre
ss
 (N
 m
 -1
)
Time (h)
e
f
(b,d,f) passivated surfaces are shown in green, monomeric protein is represented by
resent regions of growth. Three detection principles are illustrated: (a–b): QCM, (c–
pon insulin ﬁbril growth (a, blue line and b, lower schema); control measurements
a). (c) Surface plasmon resonance measurements report a response upon addition of
pon rinsing with buffer (blue line); control measurements show little ﬂuctuation
on a microcantilever (e) relative to a cantilever devoid of seeds exposed protein
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lowed using QCM and time-lapse atomic force microscopy (AFM)
after a tantalum surface was exposed to monomeric protein over
a period of 25 h [44].
An important aspect of QCM measurements is the question of
the physical origin of the resonant frequency changes. Contribu-
tions to the signal result both from an increase in mass bound to
the sensor as well as from viscous damping; this latter contribution
in turn is dependent on the surface roughness [47–51] and the vis-
co-elastic behaviour of the surrounding ﬂuid as well as of the sur-
face bound species [44,52]. It is in general not possible to predict
from ﬁrst principles the frequency shift resulting from a complex
process such as ﬁbril growth on a sensor surface, and one approach
is to calibrate the sensor response with independent AFM mea-
surements of the corresponding increase in ﬁbril length [41,42].
Alternatively, under certain conditions, the changes in surface
roughness can be neglected, and it is then possible to gain valuable
insight into the visco-elasticity of the ﬁbril layer using material
models such as the Kelvin–Voight model [53] in conjunction with
simultaneous measurements of the changes in the resonant fre-
quency and in the quality factor of the resonator [54,55]. An ele-
gant demonstration of this approach is given in Ref. [44], where
a rigid protein monolayer was observed to have formed during
the lag-phase of aggregation followed by a dramatic increase in
the viscoelasticity of the adsorbed layer attributed to subsequent
ﬁbril growth.
An alternative path for transducing chemical reactions into a
mechanical response is through the measurement of the surface
stress resulting from biomolecular assembly using microcantilever
sensors [40,56–59]. This principle has been successfully imple-Fig. 2. Tapping mode atomic force microscopy images of amyloid ﬁbrils immobilised on
gold surface. (b) Fibrils elongate following monomer addition to the seeds. (c) Sonicated
also observed post monomer addition. Images reproduced with permission from [42,80mented [60] as a label-free assay of amyloid growth (Fig. 1e and
f). Cantilever sensors offer many advantages over QCMs in terms
of parallelisation and integration with microﬂuidic systems; cur-
rently, however, the molecular origins of the differential surface
stresses associated with given chemical processes have been chal-
lenging to identify [61], and therefore at present QCMs remain
more straightforward to operate as quantitative amyloid growth
assays.
3. Surface plasmon resonance
An alternative strategy for following surface bound protein
aggregation is through the use of surface plasmon resonance
(Fig. 1d). Collective electron resonances localised at the interface
between a metal such as gold or silver and a dielectric can be ex-
cited by an incident light beam; for energy to be transferred from
the incident photons to the surface plasmons, the surface compo-
nent of the wave-vector of the light must match the wave-vector
of the plasmons in order to satisfy momentum conservation. The
characteristic angle satisfying this condition is highly sensitive to
the refractive index of the medium close to the metal surface
and can consequently be used as a probe for the adsorption of
molecules.
Surface plasmon resonance is arguably the most well-estab-
lished surface-based biosensing technique and has been exten-
sively discussed elsewhere [62–64]. The only prerequisite for
adopting SPR to study bio-interactions is, as for QCM, that one spe-
cies under investigation must be immobilised on the sensor sur-
face. This has led to a diverse range of relevant applications, from
the binding of small ligands to amyloid structures [65–69] to inter-gold biosensor surfaces. (a) Sonicated PI3K-SH3 seed ﬁbrils covalently bound to a
Ab(1–40) seed ﬁbrils immobilised on a C1 SPR gold sensor. (d) Elongated ﬁbrils are
]. Scale bars are 1 lm.
150
b
0
50
100
150
0 2 4 6 8 10
Δm
 (n
g 
cm
 -2
)
t (min)
a
1
3
2
1
2590 D.A. White et al. / FEBS Letters 583 (2009) 2587–2592actions of amyloid with lipids [70–75] and the binding of small
heat shock proteins to amyloid-related species [76–78]. Here we
focus on reports that are based on surface plasmon resonance as
an approach for monitoring the growth of amyloid ﬁbrils.
The strategies adopted for SPR assays to monitor amyloid ﬁbril
growth are closely related to those described above for QCM de-
spite differences in the physical principles underlying the detec-
tion method. One approach involves immobilisation and
extension of pre-formed seed ﬁbrils [79–81], while an alternative
method follows the complete aggregation proﬁle from monomeric
protein to mature ﬁbrils [82]. While many covalent attachment
[80,82] methods are available, the majority of SPR amyloid assays
are based on the immobilisation of the protein species on to a sen-
sor surface via amine coupling to a surface bound carboxylated
dextran matrix. Surface imaging by AFM conﬁrms that the ob-
served density increase upon exposure of monomeric protein mol-
ecules to the functionalised surface is a direct measure of ﬁbril
extension rather than non-speciﬁc binding or amorphous aggrega-
tion (Fig. 2c and d) [80,82].
SPR measurements are highly sensitive to the addition of mate-
rial to the sensor surface, for example Ab concentrations as low as
1 lM have been observed to extend immobilised amyloid ﬁbrils
[80]. The continuous ﬂow capability of biosensor methods ensures
that such low concentrations remain constant throughout experi-
mental measurements, allowing complex contributions from
monomer depletion to be omitted. Biosensor techniques also ben-
eﬁt from real-time measurements of ﬁbril growth with time inter-
vals on the order of seconds that have allowed irreversible and
reversible monomer addition to be identiﬁed [79]. Accurate tem-
perature control is an additional advantage that facilitates thermo-
dynamic measurements and has allowed determination of
activation barriers for monomer addition to amyloid ﬁbrils [80].
Several important experimental considerations must be made
when designing surface assays to allow conﬁdence in quantitative
data analysis [83]. Undesirable experimental artifacts such as non-
speciﬁc binding can be controlled either by duplicating conditions
on suitably prepared reference sensors or by optimising the surface
chemistry, for instance through the use of inert monolayers to min-
imise adsorption. An intrinsic feature of all surface-based tech-
niques is the entropic penalty associated with immobilisation of
a reactive species; attempts have been made to alleviate these ef-
fects by immobilising the reactive species on to a ﬂexible dextran
matrix. It can, however, also be argued that surface measurements
reproduce more accurately the entropic limitations that cellular
organelles, membranes and macromolecules would exert upon
protein aggregation in vivo [84].0 2 4 6 8 10
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Fig. 3. Mechanisms of amyloid growth inhibition monitored by a QCM assay. (a):
Growth inhibition by a chemical chaperone (TMAO). Insulin ﬁbrils are ﬁrst grown in
the presence of soluble protein (1), then in the presence of both protein and
chaperone (2) and ﬁnally in the presence of protein alone (3). In the absence of
chaperone, the growth resumes to the initial level, indicating no permanent
interactions between the ﬁbrils and the chaperone. In (b), the growth inhibition
assay is repeated for aB-crystallin. The growth rate (3) after exposure to chaperone
(2) is signiﬁcantly lower than that measured for pristine ﬁbrils (1), revealing a
strong interaction between the ﬁbrils and aB-crystallin as the basis of the growth
inhibition. Data from [60].4. Biosensing of amyloid binding compounds
The previous sections have outlined the potential of the QCM
and SPR techniques for monitoring directly the aggregation of
amyloid proteins. Accurate kinetic measurements of ﬁbril growth,
however, also allow the inﬂuence of disparate conditions and addi-
tional molecular species on this reaction to be studied in a quanti-
tative manner. Inhibitors of amyloid growth are of particular
biological interest, both for the understanding of the mechanisms
in place in living systems that prevent uncontrolled protein aggre-
gation and for the development of therapeutic strategies for inter-
vention in the case of protein deposition disorders.
Mechanistically, a molecular species can inhibit ﬁbril extension
through direct association with the ﬁbril and preventing ﬁbril
growth through steric inhibition or by targeting the soluble mono-
mer and blocking addition. Surface plasmon resonance and the
quartz crystal microbalance have been demonstrated as powerful
ways to monitor such inhibitory effects.Surface plasmon resonance measurements have successfully
enabled the binding afﬁnities of several ligands to monomeric Ab
to be related to inhibition of neuronal toxicity by measuring disso-
ciation constants of the ligands from the immobilised monomeric
peptide [68]. Molecular chaperones are thought to assist proteins
in achieving their native fold rather than forming a partially folded
or misfolded state that could prove toxic. In this context the bind-
ing of a family of chaperones known as small heat shock proteins
(sHsps) to monomeric amyloid proteins has been demonstrated
using SPR binding assays [76–78].
As opposed to monitoring binding of chaperones to monomeric
proteins, the quartz crystal microbalance has been used as a tool to
probe the effect of chemical and molecular chaperones on amyloid
ﬁbril extension [41]. Differential effects of a chemical chaperone
(Trimethylamine N-oxide, TMAO) and a molecular chaperone
(the sHsp aB-crystallin) were demonstrated (Fig. 3) by measuring
ﬁbril extension ﬁrst from a monomer solution, then from a mono-
mer solution also containing the chaperone molecules, and ﬁnally
from a monomer solution without chaperone once again on the
same surface. This systematic approach was able to demonstrate
that while both chaperones can signiﬁcantly inhibit ﬁbril growth,
aB-crystallin remained bound to the ﬁbrils (Fig. 3B) and inhibited
further growth on that sensor, in contrast to TMAO (Fig. 3A). Bind-
ing of a molecular chaperone to Ab ﬁbrils and a consequent inhibi-
D.A. White et al. / FEBS Letters 583 (2009) 2587–2592 2591tion of aggregation has also been demonstrated using SPR in com-
bination with ThT binding assays [85].
5. Concluding remarks
Label-free kinetic measurements of biophysical processes are
becoming a promising alternative approach to traditional spectro-
scopic methods. In particular, surface plasmon resonance and the
quartz crystal microbalance provide the basis for powerful assays
for monitoring the kinetic and thermodynamic parameters govern-
ing the elongation phase of the growth of amyloid ﬁbrils. Accurate
kinetic measurements have allowed the inﬂuence of extrinsic spe-
cies such as molecular chaperones to be determined and provide
promise for further elucidation of mechanistic details. Practical
beneﬁts such as high sensitivity, high sample throughput, short
measurement times with low volumes and facile incorporation
into existing ﬂuidic systems make surface-based biosensors an
exciting platform for developing a detailed understanding of amy-
loid growth processes using quantitative assays.
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